| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 3.607 | - | 0 | 23.654 | 18.513 | 40.155 | 14.934 | 6.649 | 12.625 |
| Total Income - EUR | - | 3.607 | - | 0 | 23.654 | 18.513 | 40.155 | 14.934 | 6.650 | 13.566 |
| Total Expenses - EUR | - | 1.255 | - | 0 | 6.835 | 5.224 | 10.172 | 4.262 | 3.588 | 4.889 |
| Gross Profit/Loss - EUR | - | 2.352 | - | 0 | 16.819 | 13.289 | 29.983 | 10.672 | 3.062 | 8.677 |
| Net Profit/Loss - EUR | - | 2.244 | - | 0 | 16.110 | 12.777 | 28.923 | 10.291 | 2.522 | 7.422 |
| Employees | - | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Malex Angiografic Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | 3.733 | - | 43 | 21.540 | 29.832 | 58.329 | 68.234 | 70.294 | 78.644 |
| Inventories | - | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 3.607 | - | 0 | 1.517 | 3.980 | 0 | 203 | 61.003 | 68.942 |
| Cash | - | 125 | - | 43 | 20.023 | 25.852 | 58.329 | 68.031 | 9.292 | 9.702 |
| Shareholders Funds | - | 2.288 | - | 43 | 16.152 | 28.623 | 56.911 | 67.378 | 69.696 | 76.728 |
| Social Capital | - | 45 | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 1.444 | - | 0 | 5.388 | 1.209 | 1.418 | 856 | 598 | 1.916 |
| Income in Advance | - | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4619 - 4619" | |||||||||
| CAEN Financial Year |
4619
|
|||||||||
Comments - Malex Angiografic Srl